Shelf life (days): 365.0
Formulation: A solution in ethanol
Formal Name: (2S)-2-phenyl-4-[6-[[cis-3-(1H-pyrazol-1-yl)cyclobutyl]oxy]-4-pyrimidinyl]-morpholine
Purity: ≥98%
Formula Markup: C21H23N5O2
Formula Weight: 377.43982
CAS Number: 2761063-99-2
Notes: ELOVL1-22 is an inhibitor of ELOVL fatty acid elongase 1 (ELOVL1).{62719} It reduces lysohexacosanoylphosphatidylcholine (LPC(C26:0)) synthesis in HEK293 cells (IC50 = 400 pM), a marker of ELOVL1 inhibition, and is selective for ELOVL1 over ELOVL4, -6, and -7 (IC50s = >50 µM for all), as well as a panel of 34 receptors at 10 µM. ELOVL1-22 (1-32 mg/kg) reduces blood and CNS levels of LPC(C26:0) in an Abcd1-/- mouse model of adrenoleukodystrophy (ALD), a neurodegenerative disease characterized by rapid inflammatory demyelination of the CNS.